You are here

DEVELOPMENT AND EVALUATION OF TROCHES CONTAINING CHLORHEXIDINE HCL AND TRIAMCINOLONE FOR TREATMENT OF DENTAL PLAQUE, GINGIVITIS AND MOUTH ULCERS

Journal Name:

Publication Year:

Abstract (2. Language): 
The mouth of human body provides non (teeth) for natural microbial colonization. This can the accumulation of large masses of bacteria and their products at stagnant sites. Dental plaque and gingivitis are some of this type of conditions, which can develop due to microbial accumulation on teeth. And mouth ulcers are small, painful sores on the inside lining of the mouth. Chlorhexidine is widely used antimicrobial drug in treatment of dental plaque and gingivitis and triamcinolone is used as anti ulcerative as well as anti-inflammatory. A troche is a lozenge designed to deliver medications directly to the mucus membranes of the mouth by dissolving slowly when placed between the tongue and gums. Validated HPLC method was developed for quantitative estimation of Chlorhexidine HCl and Triamcinolone in dosage forms. Optimized mobile phase for these two drugs was 2.0 g of sodium octane sulphonate in a mixture of 120 ml of glacial acetic acid, 270 ml of water and 730 ml of methanol, and retention time was found as 9.8 and 4.2 minutes respectively for Chlorhexidine HCl and Triamcinolone.
FULL TEXT (PDF): 
211-237

REFERENCES

References: 

1. Jones CG: Chlorhexidine: Is it still the
gold standard? Periodontology 2000; 15:
55-62.
2. Emilson CG: Potential efficacy of
chlorhexidine against mutans streptococci
and human dental caries. J Dent Res 1994;
73: 682-691.
3. Grossman E, Reiter GP, Sturzenberg OP,
De La Rosa M, Dickinson TD and Ferreti GA:
Six month study of the effects of a
chlorhexidine mouthrinse on gingivitis in
adults. J Periodont Res 1986; 21: 33-43.
4. Adams D and Addy M: Mouthrinses. Adv
Dent Res 1994; 8: 291-301.
5. Rolla G and Melsen B: On the mechanism
of the plaque inhibition of chlorhexidine. J
Dent Res 54 (special issue B) 1975: 54-62.
6. Dollery C: Therapeutics drugs, brace and
company limilrt. 1999; 2(1): 175-176.
7. Ministery of Health and Science Welfare.
Indian Pharmacopoeia, Government of
India, New Delhi. 1996; I, II, III.
8. van der Bijl P and Dreyer WP:
Chlorhexidine gluconate mouthrinse -
further aspects concerning its chemical
compatibility, stability and detection of
potentially harmful degradation products. J
Dent Assoc South Africa 1982; 37: 741-745.
9. Gardner JF and Gray KG: Chlorhexidine.
In: Disinfection, Sterilization and
Preservation. Block SS. ed. 2nd edn. 251-
270. Lea & Febiger, Philadelphia 1983
10. Cury JA: Effect of Saccharin on
Antibacterial Activity of Chlorhexidine HCL
Gel". Braz Dent J. 2000; 11(1): 29-34.
11. Marsh PD: Host defences and microbial
homeostasis: role of microbial interactions.
J Dent Res. 1989; 68: 1567-1575.
12. Marsh PD: Dental plaque as a bio-film.
Journal of Industrial Microbiology. 1995; 15:
169-175.
13. Moore AV: Bacteriology of human
gingivitis. J Dent Res. 1987; 66: 989-995.
REFERENCES
Research Article ISSN: 2277-8713
Manisha Patel, IJPRBS, 2012; Volume 1(5): 211-237 IJPRBS
Available Online At www.ijprbs.com
14. Wise GEEK Copyright© Troches.
Conjecture Corporation; 2003–2011.
15. Rowe RC: Handbook of Pharmaceutical
Excipients. Pharmaceutical Press and
American Pharmacists Association. 2009;
(6): 404-786.
16. Swarbrick J: Encyclopedia of
pharmaceutical, “Preparation of Tablet
Technology”; (3): 3673-3675.
17. Lieberman HA: Pharmaceuticals dosage
forms tablet. Marcel dekker Inc. 1989; 1(2):
419,543-557.
18. Roydan: United States of Pharmacopeia.
“Stability Study”. 2008: 2396.

Thank you for copying data from http://www.arastirmax.com